Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-grade glioma in elderly patients: can the oncogeriatrician help?
Tabouret E, Tassy L, Chinot O, Crétel E, Retornaz F, Rousseau F. Tabouret E, et al. Among authors: tassy l. Clin Interv Aging. 2013;8:1617-24. doi: 10.2147/CIA.S35941. Epub 2013 Dec 6. Clin Interv Aging. 2013. PMID: 24353408 Free PMC article. Review.
Emerging therapies for soft-tissue sarcomas.
Levard A, Tassy L, Cassier PA. Levard A, et al. Among authors: tassy l. Hematol Oncol Clin North Am. 2013 Oct;27(5):1063-78. doi: 10.1016/j.hoc.2013.07.011. Hematol Oncol Clin North Am. 2013. PMID: 24093176 Review.
Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization.
Castel P, Tassy L, Lurkin A, Blay JY, Meeus P, Mignotte H, Faure C, Ranchere-Vince D, Bachelot T, Guastalla JP, Sunyach MP, Guerin N, Treilleux I, Marec-Berard P, Thiesse P, Ray-Coquard I. Castel P, et al. Among authors: tassy l. Bull Cancer. 2012 Apr 1;99(4):E34-42. doi: 10.1684/bdc.2012.1559. Bull Cancer. 2012. PMID: 22455955
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).
Corre R, Gervais R, Guisier F, Tassy L, Vinas F, Lamy R, Fraboulet G, Greillier L, Doubre H, Descourt R, Chouaid C, Auliac JB. Corre R, et al. Among authors: tassy l. Oncotarget. 2018 Jan 2;9(9):8253-8262. doi: 10.18632/oncotarget.23836. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492192 Free PMC article.
17 results